ProMIS Neurosciences to voluntarily delist from TSX, consolidate trading to Nasdaq

ProMIS Neurosciences Inc.

Voluntary delisting from TSX effective as of close of trading on July 21, 2023.
Common shares will continue to trade on Nasdaq under symbol PMN without interruption.
Company cites cost savings and management time savings from eliminating dual listing.
Shareholder approval not required; Nasdaq is deemed an acceptable alternative market by TSX.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.